Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Survey on Interdisciplinary Management of Cardiotoxicity in Outpatient Sett
Author(s): Silvio Quick , Lorena Payo-Anez , Clara Marx Casimiro de Almeida , et al Added: 1 year ago

Guidelines & Statements

Imaging & Diagnostics
Frailty in Cardio-oncology
Author(s): Ilaria Torre , Lorenzo Tinti , Ludovica Amore , et al Added: 3 days ago

CV Disease in Special Populations

Heart Failure
Advances in Cardioprotection Strategies: Focusing on Breast Cancer and Beyond Through Novel Biomarkers and Pharmacological Approaches
Author(s): Giulia Tamburrini , Celia de Cobos García , Teresa López Fernández Added: 5 months ago

CV Disease in Special Populations

Heart Failure
Dr Lorcan Ruane recently completed a cardio-oncology fellowship at the Royal Brompton Hospital in London. He was trained in general cardiology in Brisbane, Australia and has also completed a fellowship in advanced echocardiography. His cardio-oncology interests include immunotherapy toxicities, cardiotoxicity monitoring and survivorship. Dr Ruane has now returned to Brisbane where he is building… View more
Frailty and Cardio-oncology
Author(s): Erkihun Amsalu , Tan Van Nguyen , Harry Klimis , et al Added: 2 months ago

CV Disease in Special Populations

Heart Failure
Emerging Toxicities, Translational Research and Reverse Cardio-oncology
Author(s): Massimiliano Camilli , Luca Maggio , Lorenzo Tinti , et al Added: 11 months ago

CV Disease in Special Populations

Heart Failure
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

 Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more
ACC.24: Preventing Chemotherapy-Related Heart Damage in Patients with Breast Cancer and Lymphoma: PROACT
Author(s): David Austin Added: 1 year ago
ACC.24 — We are joined onsite by Dr David Austin (South Tees Hospitals NHS Foundation Trust, UK) to discuss the findings from the PROACT trial (NCT03265574).Anthracyclines used in the treatment of breast cancer cause damage to the muscle cells in the heart, resulting in cardiotoxicity.PROACT is a phase III randomised superiority trial of enalapril for the prevention of anthracycline-induced… View more

CV Disease in Special Populations
Research Area(s) / Expertise: Job title: Consultant Cardiologist
Dr Daniel Chen is a Consultant Cardiologist at the Prince of Wales & St George Hospitals,Sydney, AU. He is also a senior lecturer and researcher through the Hatter Cardiovascular Institute at University College London (UCL). Dr Chen specialises in cardio-oncology, heart failure and cardiac imaging. His research interests include cardiotoxicities associated with immunotherapies and in breast… View more
Ian Paterson
Job title: Professor
Dr Ian Paterson is a Professor of Medicine in the Division of Cardiology at the University of Alberta. He completed his Cardiology training and an Echocardiography Fellowship at the McGill University, followed by a Cardiovascular MRI Fellowship at the National Institutes of Health. Dr Paterson is also the Academic and Research Director of Cardiovascular Magnetic Resonance at the University of… View more